VFC vs XENE · P/E 26, rev $9.61B vs $2.55B cap
VF Corporation (VFC) versus Xenon Pharmaceuticals Inc (XENE) — a side-by-side from cached financials, not a winner call.
VF Corporation (VFC) is a apparel manufacturing company listed on NYSE.
Xenon Pharmaceuticals Inc (XENE) is a biotechnology company listed on US.
Latest reported VFC revenue for 2026-03-28 was $9.61B. Net income was $254.9M. Revenue was up 1.1% from 2025-03-29 to 2026-03-28. VFC currently screens at market cap $6.55B and trailing P/E 26.1.
Latest reported XENE revenue for 2026-06-30 was $0. Net income was -$213.0M. XENE currently screens at market cap $2.55B.
VFC currently screens at market cap $6.55B and trailing P/E 26.1. XENE currently screens at market cap $2.55B.
Not investment advice. Open the VFC and XENE stock pages for the full models.
Not investment advice.